A group of researchers recently published a paper in the MDPI journal pharmaceutics that demonstrated the effectiveness of using lipid-biopolymer nanobeads as indomethacin (INDO) carriers to reduce drug toxicity.
Background
INDO, an orally administered non-steroidal anti-inflammatory (NSAID) agent, is used extensively for inflammation, fever, and pain control. However, the oral administration of INDO often leads to severe side effects, specifically in the gastrointestinal system, such as abdominal ache, indigestion, and diarrhea owing to the first-pass metabolism. Thus, new approaches are being investigated to lessen the INDO systemic toxicity and improve its overall efficacy.
Figure 1. Long-term stability of NLC formulations, monitored in terms of size (A), PDI (B), Zeta potential (C) and pH (D) values for up to a year, at 25 °C (n = 3; p < 0.05). © Bonetti, F.M.R., de Paula, E., Fonseca, B.B. et al. (2022)
Colloidal drug delivery systems (DDS) with improved therapeutic actions can reduce the side effects by releasing the loaded drugs in a sustained manner. For instance, nanostructured lipid carriers (NLC) can be used to load and deliver various anti-inflammatory compounds through several drug administration routes. However, NLC as a colloid cannot provide the mucoadhesion and gastro-resistance required for oral administration of INDO.
Lipid–polymer nanohybrid formulations that contain at least a single nanostructured material in their composition can potentially merge the benefits of every excipient/carrier within a single DDS. Biopolymers are widely utilized as DDS as they are biodegradable, biocompatible, and versatile in nature. For instance, chitosan, a cationic polysaccharide, possesses exceptional mucoadhesive properties, which can be suitable for INDO administration.
However, chitosan displays sensitivity to acid media such as the gastric microenvironment. This issue can be resolved using xanthan gum (XAN), an anionic exopolysaccharide, as the coating agent of the lipid-polymer nanohybrid formulations such as nanobeads.
The Study
In this study, researchers combined two distinct strategies of coating and hybridization to decrease the INDO systemic toxicity and extend its release profile by simulating an oral administration. Initially, lipid–biopolymer nanobeads were synthesized in which NLC blended with chitosan solution encapsulated the INDO, and the nanobeads were coated by XAN. Later, they investigated the efficacy of the synthesized nanobeads and the reduction in INDO toxicity due to them.
Figure 2. Digital photo (left) of hybrid nanobeads (XAN@CHT/NLC-INDO) and particle size distribution (right), estimated by ImageJ software, (n = 3). © Bonetti, F.M.R., de Paula, E., Fonseca, B.B. et al. (2022)
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), chitosan, XAN, INDO, Pluronic® 68 (P68), poloxamer, myristyl myristate (MM), coconut oil (CO), and deionized (DI) water with 18 MΩ resistivity were used as the starting materials.
2%, w/v NLC/INDO and NLC as control formulation were synthesized by the ultrasonication emulsification method, where MM acted as a solid lipid, poloxamer as a surfactant, and CO as a liquid lipid. Under magnetic stirring, the lipid phase containing CO and MM was briefly heated without or with 2% INDO at 10oC above the solid lipid melting point.
The aqueous phase containing 2-5% P68 was also heated at a similar temperature and then added to the lipid phase under high-speed homogenization for 3 min at 10,000 rpm in an Ultra-Turrax blender. Eventually, the obtained microemulsion was tip-sonicated at 20 kHz and 500 W in 30 s (on/off) cycles for 20 min, and then cooled in an ice bath to 25oC.
The polydispersity index (PDI) and particle size of the synthesized NLC/INDO and NLC formulations were determined using the dynamic light scattering (DLS) method, while the Zetasizer Nano ZS90 equipment was employed to measure their zeta potential values by electrophoretic light scattering. Researchers also determined the long-term physicochemical stability and in vitro cell viability of the samples and the INDO encapsulation efficiency.
Chitosan was scattered in 50 mL of 0.1% acetic acid, and XAN was dissolved in 50 mL DI water under magnetic stirring. Subsequently, 2% hydroalcoholic INDO solution was mixed with the chitosan solution and stirred at room temperature for 2 h to obtain chitosan/INDO beads.
In the preparation of chitosan/NLC-INDO hybrid nanobeads, half of the acetic acid solution was replaced with NLC loaded with 2% INDO for chitosan solubilization. The final XAN-coated forms were synthesized by initially immersing the aliquots of chitosan/NLC-INDO nanobeads and chitosan/INDO beads into 0.5% w/v XAN aqueous solution, then filtering and cooling them to −20oC, and finally freeze-drying.
Researchers performed the water uptake test and the INDO release test in in vitro mode, and in vivo toxicity assays through the chicken embryo model on the samples.
Observations
Ten distinct NLC formulations without and with INDO were successfully synthesized that showed a pale white color and a homogenous aspect. The physicochemical properties of NLC formulations remained suitable for use even after one year of storage, which indicated their long-term stability, and their INDO encapsulation efficiency was 99%.
The hybrid nanobeads of XAN-coated chitosan and NLC/INDO displayed exceptional thermodynamic, structural, and in vitro swelling properties, which indicated excellent compatibility between the biomaterials, and an extended drug release profile up to 26 hours.
Figure 3. Indomethacin in vitro release from beads (CHT/INDO and XAN@CHT/INDO) and nanobeads (CHT/NLC-INDO and XAN@CHT/NLC-INDO), quantified by UV-vis (λ = 210 nm) at 37 °C, n = 5. © Bonetti, F.M.R., de Paula, E., Fonseca, B.B. et al. (2022)
The synergism observed between the biopolymer and nanolipid excipients helped in preventing the burst release effect within the first two hours of experiments, which simulated a gastric medium, followed by an extended-release in the pH 6.8, simulating an intestinal medium.
The XAN coating on nanobeads acted as a gastro-resistant excipient that protected chitosan and NLC/INDO from an unexpected swelling and prevented drug release in the initial hours of experiments.
The safety of the nanobeads was confirmed in the in vivo toxicity assay in chicken embryos (CE) as the combined benefits of coating and hybridization procedures reduced the inherent toxicity of INDO in chicken embryos.
Taken together, the findings of this study demonstrated that the lipid–biopolymer nanobead can be effectively used for delivering INDO, and other anti-inflammatories, through oral administration.
News
Antibiotic Breakthrough: Revolutionary Chinese Study Paves Way for Superbug Defeating Drugs
New research reveals that fluorous lipopetides act as highly effective antibiotics. Bacterial infections resistant to multiple drugs, which no existing antibiotics can treat, represent a significant worldwide challenge. A research group from China has [...]
Signs of Multiple Sclerosis Show Up in Blood Years Before Symptoms Appear
UCSF scientists clear a potential path toward earlier treatment for a disease that affects nearly 1,000,000 people in the United States. By Levi Gadye In a discovery that could hasten treatment for patients with multiple [...]
Advanced RNA Sequencing Reveals the Drivers of New COVID Variants
A study reveals that a new sequencing technique, tARC-seq, can accurately track mutations in SARS-CoV-2, providing insights into the rapid evolution and variant development of the virus. The SARS-CoV-2 virus that causes COVID has the unsettling [...]
No More Endless Boosters? Scientists Develop One-for-All Virus Vaccine
End of the line for endless boosters? Researchers at UC Riverside have developed a new vaccine approach using RNA that is effective against any strain of a virus and can be used safely even by babies or the immunocompromised. Every [...]
How Are Hydrogels Shaping the Future of Biomedicine?
Hydrogels have gained widespread recognition and utilization in biomedical engineering, with their applications dating back to the 1960s when they were first used in contact lens production. Hydrogels are distinguished from other biomaterials in [...]
Nanovials method for immune cell screening uncovers receptors that target prostate cancer
A recent UCLA study demonstrates a new process for screening T cells, part of the body's natural defenses, for characteristics vital to the success of cell-based treatments. The method filters T cells based on [...]
New Research Reveals That Your Sense of Smell May Be Smarter Than You Think
A new study published in the Journal of Neuroscience indicates that the sense of smell is significantly influenced by cues from other senses, whereas the senses of sight and hearing are much less affected. A popular [...]
Deadly bacteria show thirst for human blood: the phenomenon of bacterial vampirism
Some of the world's deadliest bacteria seek out and feed on human blood, a newly-discovered phenomenon researchers are calling "bacterial vampirism." A team led by Washington State University researchers has found the bacteria are [...]
Organ Architects: The Remarkable Cells Shaping Our Development
Finding your way through the winding streets of certain cities can be a real challenge without a map. To orient ourselves, we rely on a variety of information, including digital maps on our phones, [...]
Novel hydrogel removes microplastics from water
Microplastics pose a great threat to human health. These tiny plastic debris can enter our bodies through the water we drink and increase the risk of illnesses. They are also an environmental hazard; found [...]
Researchers Discover New Origin of Deep Brain Waves
Understanding hippocampal activity could improve sleep and cognition therapies. Researchers from the University of California, Irvine’s biomedical engineering department have discovered a new origin for two essential brain waves—slow waves and sleep spindles—that are critical for [...]
The Lifelong Cost of Surviving COVID: Scientists Uncover Long-Term Effects
Many of the individuals released to long-term acute care facilities suffered from conditions that lasted for over a year. Researchers at UC San Francisco studied COVID-19 patients in the United States who survived some of the longest and [...]
Previously Unknown Rogue Immune Key to Chronic Viral Infections Discovered
Scientists discovered a previously unidentified rogue immune cell linked to poor antibody responses in chronic viral infections. Australian researchers have discovered a previously unknown rogue immune cell that can cause poor antibody responses in [...]
Nature’s Betrayal: Unmasking Lead Lurking in Herbal Medicine
A case of lead poisoning due to Ayurvedic medicine use demonstrates the importance of patient history in diagnosis and the need for public health collaboration to prevent similar risks. An article in CMAJ (Canadian Medical Association [...]
Frozen in Time: How a DNA Anomaly Misled Scientists for Centuries
An enormous meteor spelled doom for most dinosaurs 65 million years ago. But not all. In the aftermath of the extinction event, birds — technically dinosaurs themselves — flourished. Scientists have spent centuries trying [...]
‘Mini kidneys’ reveal new insights into metabolic defects in polycystic kidney disease
Scientists at Nanyang Technological University, Singapore (NTU Singapore) have successfully grown 'mini kidneys' in the lab and grafted them into live mice, revealing new insights into the metabolic defects and a potential therapy for [...]